CBG (Cannabigerol): Non-psychoactive, sleep inducing. Anti-microbial. Lowers intra-ocular pressure (IOP) Glaucoma. Trends in Pharmacological Sciences Volume 30, Issue 10, October 2009, Pages 515-527
CBC (Cannabichromene): Sedative effect. Moderates effects of THC. Analgesic (pain relieving). Non-psychoactive. Trends in Pharmacological Sciences
Volume 30, Issue 10, October 2009, Pages 515-527
THCV (Tetrahydrocannabivarin): Stronger, faster “high” effect. Apatite suppressant. Euphoria, analgesic (pain relieving).
THC (tetrahydrocannabinol): Psychotropic. Analgesic (pain relieving). Apatite stimulant. Bronchial dilator. Lowers IOP/glaucoma.
CBD (Cannabidiol): Non-psychoactive. Reduces muscle spasms. Muscle relaxant. Analgesic (pain relieving) Trends in Pharmacological Sciences
Volume 30, Issue 10, October 2009, Pages 515-527
CBN (Cannabinol): Mildly psychoactive. Non-narcotic analgesic (pain relieving). Good indication of medications age. Trends in Pharmacological Sciences
Volume 30, Issue 10, October 2009, Pages 515-527
_____________________________________________________________________________________________
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ(9) -tetrahydrocannabinol in BV-2 microglial cells. -- http://www.ncbi.nlm.nih.gov/pubmed/21542829
The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells. -- http://www.ncbi.nlm.nih.gov/pubmed/21533611
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells. -- http://www.ncbi.nlm.nih.gov/pubmed/19910459
Scientists Uncover How CBD Treats MS, Alters Cholesterol Metabolism -- http://www.freedomisgreen.com/cbd-in-marijuana-treats-ms-alters-cholesterol-metabolism/
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. -- http://www.ncbi.nlm.nih.gov/pubmed/20002104
Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance. -- http://www.ncbi.nlm.nih.gov/pubmed/11229617
THC May Improve Driving Ability in Patients with Neurological Diseases -- http://www.freedomisgreen.com/thc-may-improve-driving-ability-in-patients-with-neurological-diseases/
Cannabis is more than simply Δ9-tetrahydrocannabinol -- http://www.springerlink.com/content/gefrp0xg76d72926/
I have plenty more sources for those who want them. Shredder I recommend you do some studying of the endocannabinoid : ) ANd remember folks that just looking at the CANNABINOIDS not even talking the subtle effects of the Terpenes. (And for those of you that say why do they matter, take for instance B-Carophyllene which doacks at the CB2 receptor
)
~Digi